Gradipore has appointed Australian businessman Jeremy Davis as its new chairman of the board. [ + ]

A link between heart disease and the consumption of milk protein beta casein A1 has been demonstrated in a study performed by Queensland researchers for New Zealand biotech company A2 Corporation. [ + ]

Adelaide gene-discovery company Bionomics has announced it has successfully filed a patent under the international Patent Cooperation Treaty on 114 novel genes involved in angiogenesis, the process of blood-vessel growth. [ + ]

The crystal ball has cleared, and a Melbourne research team has seen one of the shapes of the future in cancer research, after solving the elusive structure of a receptor for a growth factor involved in many common cancers. [ + ]

A landmark survey of the commercialisation track record by Australia's publicly-funded research bodies shows worrying weak spots in a generally favourable picture. [ + ]

Australian biotech hopeful Peptech got the green light from the US patents office for its Tumour Necrosis Factor Antibodies technique this week. [ + ]

Natural health products company VRI Biomedical has reason to be upbeat about its future despite posting the largest annual loss in its short history. [ + ]

The hope of millions of patients was riding on politics far more than science, paralysed actor and stem cell research advocate Christopher Reeve told delegates in a taped keynote speech at the Stem Cells 2002 conference this week. [ + ]

The Federal government's 'Backing Australia's Ability' package seems to have backed right over small biotechnology companies, crushing their hopes for substantial cash rebates on their R&D expenditure. [ + ]

Perth-based cancer therapeutics company Australian Cancer Technology announced today that researchers at St Vincent's Hospital, Sydney have begun analysing results from the first group of patients in its Phase Ib/IIa clinical trial of its Pentrix vaccine for common cancers. [ + ]

A star-studded cast of researchers strongly seasoned with Australians has launched an ambitious bid to develop the next-generation bioinformatics needed to unravel the complexities of the phenome. [ + ]

Researchers in the UK are developing a kind of biosensor which can determine in minutes if an overdose patient's blood contains a particular compound, for example paracetamol. Currently, this type of examination needs to be carried out in a laboratory and which is expensive and time-consuming.

Drug developer Progen Industries is licensing development rights to a new patented cancer therapy from the University of New South Wales. [ + ]

A biotech company in the forefront of mining Australia's natural biodiversity for blockbuster commercial applications is approaching its moment of truth. [ + ]

Porous silicon drug delivery company pSivida has received a multimillion dollar vote of confidence in its prospects from New York's GEM private equity group. [ + ]